Ester del Barrio-Tofiño

Author

Health Research Institute of the Balearic Islands ORCID

Also Known As

Eduardo Padilla, Ester Del Barrio-Tofiño, Ester del Barrio-Tofiño

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Health Research Institute of the Balearic Islands Hospital Universitario Son Espases University of Córdoba Instituto Maimónides de Investigación Biomédica de Córdoba Instituto de Investigación Biomédica de A Coruña

About

Ester del Barrio-Tofiño is an author at Health Research Institute of the Balearic Islands specializing in bacterial resistance, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	89
2	Microbiology	2	2	89
3	Health Sciences	1	1	11
4	Pharmacology	1	1	11
5	Antibiotics	1	1	11

Ester del Barrio-Tofiño

Publications

808

Citations

H-Index

Page 1

	Year	Citations
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain Ester del Barrio-Tofiño, Carla López-Causapé, Gabriel Cabot, Antimicrobial Agents and Chemotherapy	2017	167
Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology Ester del Barrio-Tofiño, Laura Zamorano, Sara Cortés-Lara, Journal of Antimicrobial Chemotherapy	2019	144
Susceptibility profiles and resistance genomics of <i>Pseudomonas aeruginosa</i> isolates from European ICUs participating in the ASPIRE-ICU trial Gabriel Torrens, Thomas van der Schalk, Sara Cortés-Lara, Journal of Antimicrobial Chemotherapy	2022	81
Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants Pablo A. Fraile-Ribot, Laura Zamorano, Rocío Orellana, Antimicrobial Agents and Chemotherapy	2019	80
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis Sara Cortés-Lara, Ester del Barrio-Tofiño, Carla López-Causapé, Clinical Microbiology and Infection Antimicrobial Resistance GeneAntimicrobial SusceptibilityGeneticsMicrobiologyAntibiotic Resistance	2021	78
Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection Rachel M. Wheatley, Julio Diaz Caballero, Natalia Kapel, Nature Communications	2021	75
<i>In Vivo</i> Emergence of Resistance to Novel Cephalosporin–β-Lactamase Inhibitor Combinations through the Duplication of Amino Acid D149 from OXA-2 β-Lactamase (OXA-539) in Sequence Type 235 Pseudomonas aeruginosa Pablo A. Fraile-Ribot, Xavier Mulet, Gabriel Cabot, Antimicrobial Agents and Chemotherapy	2017	70
Emergence of Resistance to Novel Cephalosporin–β-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump María A. Gomis-Font, Cristina Pitart, Ester del Barrio-Tofiño, Antimicrobial Agents and Chemotherapy	2021	49
Association between Pseudomonas aeruginosa O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey Ester del Barrio-Tofiño, Irina Sánchez-Diener, Laura Zamorano, Journal of Antimicrobial Chemotherapy	2019	27
Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis Soraya Herrera-Espejo, Ester del Barrio-Tofiño, Tania Cebrero-Cangueiro, Antibiotics	2022	13

Page 1